BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22210756)

  • 1. Nosocomial spread of multidrug-resistant group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1.
    Nagano N; Nagano Y; Toyama M; Kimura K; Tamura T; Shibayama K; Arakawa Y
    J Antimicrob Chemother; 2012 Apr; 67(4):849-56. PubMed ID: 22210756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of fluoroquinolone- and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility.
    Kimura K; Nagano N; Nagano Y; Suzuki S; Wachino J; Shibayama K; Arakawa Y
    J Antimicrob Chemother; 2013 Mar; 68(3):539-42. PubMed ID: 23111853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predominance of sequence type 1 group with serotype VI among group B streptococci with reduced penicillin susceptibility identified in Japan.
    Kimura K; Nagano N; Nagano Y; Wachino J; Suzuki S; Shibayama K; Arakawa Y
    J Antimicrob Chemother; 2011 Nov; 66(11):2460-4. PubMed ID: 21873288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy.
    Gherardi G; Imperi M; Baldassarri L; Pataracchia M; Alfarone G; Recchia S; Orefici G; Dicuonzo G; Creti R
    J Clin Microbiol; 2007 Sep; 45(9):2909-16. PubMed ID: 17634303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-level transition of capsular polysaccharide types among sequence type 1 group B Streptococcus isolates with reduced penicillin susceptibility during a long-term hospital epidemic.
    Nagano N; Koide S; Hayashi W; Taniguchi Y; Tanaka H; Maeyama Y; Suzuki M; Kimura K; Arakawa Y; Nagano Y
    Int J Antimicrob Agents; 2019 Mar; 53(3):203-210. PubMed ID: 30414439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Analysis of Penicillin-Susceptible and Non-Susceptible Isolates of Group B Streptococci by Multilocus Sequence Typing.
    Yamada R; Kimura K; Nagano N; Nagano Y; Suzuki S; Jin W; Wachino J; Yamada K; Shibayama K; Arakawa Y
    Jpn J Infect Dis; 2015; 68(4):326-9. PubMed ID: 25720637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive neonatal GBS infections from an area-based surveillance study in Italy.
    Imperi M; Gherardi G; Berardi A; Baldassarri L; Pataracchia M; Dicuonzo G; Orefici G; Creti R
    Clin Microbiol Infect; 2011 Dec; 17(12):1834-9. PubMed ID: 21722258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First molecular characterization of group B streptococci with reduced penicillin susceptibility.
    Kimura K; Suzuki S; Wachino J; Kurokawa H; Yamane K; Shibata N; Nagano N; Kato H; Shibayama K; Arakawa Y
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2890-7. PubMed ID: 18490507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High isolation rate of MDR group B streptococci with reduced penicillin susceptibility in Japan.
    Seki T; Kimura K; Reid ME; Miyazaki A; Banno H; Jin W; Wachino J; Yamada K; Arakawa Y
    J Antimicrob Chemother; 2015 Oct; 70(10):2725-8. PubMed ID: 26169560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and bacterial features of Group B streptococci with reduced penicillin susceptibility from respiratory specimens: a case-control study.
    Nishiyama N; Kinjo T; Uechi K; Parrott G; Nakamatsu M; Tateyama M; Fujita J
    Eur J Clin Microbiol Infect Dis; 2022 Jan; 41(1):1-8. PubMed ID: 34383176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of erythromycin-resistant Streptococcus agalactiae strains.
    Domelier AS; van der Mee-Marquet N; Arnault L; Mereghetti L; Lanotte P; Rosenau A; Lartigue MF; Quentin R
    J Antimicrob Chemother; 2008 Dec; 62(6):1227-33. PubMed ID: 18786936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization and antimicrobial susceptibility profiles in Streptococcus agalactiae colonizing strains: association of erythromycin resistance with subtype III-1 genetic clone family.
    Florindo C; Viegas S; Paulino A; Rodrigues E; Gomes JP; Borrego MJ
    Clin Microbiol Infect; 2010 Sep; 16(9):1458-63. PubMed ID: 19886900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominance of clonal complex 10 among the levofloxacin-resistant Streptococcus agalactiae isolated from bacteremic patients in a Korean hospital.
    Ryu H; Park YJ; Kim YK; Chang J; Yu JK
    J Infect Chemother; 2014 Aug; 20(8):509-11. PubMed ID: 24880684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone-Resistant
    Arias B; Kovacec V; Vigliarolo L; Suárez M; Tersigni C; Müller L; Lopardo H; Bonofiglio L; Mollerach M
    Microb Drug Resist; 2019 Jun; 25(5):739-743. PubMed ID: 30676886
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiclonal emergence of levofloxacin-resistant group B Streptococcus, Taiwan.
    Wu CJ; Lai JF; Huang IW; Hsieh LY; Wang HY; Shiau YR; Lauderdale TL
    J Antimicrob Chemother; 2017 Dec; 72(12):3263-3271. PubMed ID: 28961888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness.
    Soriano F; Cafini F; Aguilar L; Tarragó D; Alou L; Giménez MJ; Gracia M; Ponte MC; Leu D; Pana M; Letowska I; Fenoll A
    J Antimicrob Chemother; 2008 Dec; 62(6):1234-40. PubMed ID: 18799472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand.
    Malbruny B; Werno AM; Anderson TP; Murdoch DR; Leclercq R
    J Antimicrob Chemother; 2004 Dec; 54(6):1040-4. PubMed ID: 15537693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal dissemination of invasive and colonizing clonal complex 1 of serotype VI group B Streptococcus in central Taiwan.
    Lin HC; Chen CJ; Chiang KH; Yen TY; Ho CM; Hwang KP; Su BH; Lin HC; Li TC; Lu JJ
    J Microbiol Immunol Infect; 2016 Dec; 49(6):902-909. PubMed ID: 25560254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and epidemiology of levofloxacin resistance in Streptococcus pneumoniae: experience from a tertiary referral hospital in England.
    Orr D; Wilkinson P; Moyce L; Martin S; George R; Pichon B
    J Antimicrob Chemother; 2010 Mar; 65(3):449-52. PubMed ID: 20019170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.